The effect of selective serotonin reuptake inhibitor treatment of panic disorder on emergency room and laboratory resource utilization

Journal of Clinical Psychiatry

Volumn 62, Issue 9, 2001, Pages 678-682

  Roy Byrne, P P ^a   Clary, C M ^a   Miceli, R J ^a   Colucci, S V ^a   Xu, Y ^a   Grudzinski, A N ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; FLUOXETINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; ARTICLE; DATA BASE; EMERGENCY WARD; FEMALE; FOLLOW UP; HEALTH CARE; HUMAN; LABORATORY; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; PANIC; PRIORITY JOURNAL; RESOURCE MANAGEMENT;

EID: 0034783188     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v62n0903     Document Type: Article

References (26)

1. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey
2. Chest pain: Relationship of psychiatric illness to coronary arteriographic results
3. Psychiatric illness and irritable bowel syndrome: A comparison with inflammatory bowel disease
4. Panic disorder in patients attending a clinic for vestibular disorders
5. Somatization and psychiatric disorder in the NIMH Epidemiologic Catchment Area study
6. Panic disorder in emergency department chest pain patients: Prevalence, comorbidity, suicidal ideation, and physician recognition
7. Estimated prevalences of panic disorder and depression among consecutive patients seen in an emergency department with acute chest pain
8. Distressed high utilizers of medical care: DSM-III-R diagnoses and treatment needs
9. Controlled comparison of the characteristics of patients with panic disorder
10. Panic disorder in the primary care setting: Comorbidity, disability, service utilization, and treatment
11. The economic burden of anxiety disorders in the 1990s
12. The economic burden of depression in 1990
13. Pharmacotherapy of panic disorder: Proposed guidelines for the family physician
14. Advances in the psychosocial treatment of anxiety disorders: Implications for national health care
15. Utilization of behavioral methods in a multicenter anxiety disorders study
16. Panic attacks in the community: Social morbidity and health care utilization
17. Psychiatric disorder and functional somatic symptoms as predictors of health care use
18. Costs and offset effect in panic disorders
19. Pre-treatment predictors of treatment outcome in panic disorder and agoraphobia treated with alprazolam and exposure
20. Predictors of short-term treatment response in 66 patients with panic disorder
21. Anxiety psychopathology predictive of outcome in patients with panic disorder and depression treated with imipramine, alprazolam and placebo
22. Epidemiological data of patients treated with fluvoxamine: Results from a 12 week non-comparative multicentre study
23. Generalized models with selectivity
24. A randomized trial of collaborative care for patients with panic disorder in primary care
25. Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder
26. Outcome assessment and clinical improvement in panic disorder: Evidence from a randomized controlled trial of fluoxetine and placebo